Gene · 7498
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential candidates from a functional food Zanthoxyli Pericarpium (Sichuan pepper) for the management of hyperuricemia: high-through virtual screening, network pharmacology and dynamics simulations. | Front Endocrinol (Lausanne) | 2024 | 39722812 | PubTator, text mining | PubMed |
Which casein micelle removal method is suitable for studies of human milk extracellular vesicles? A systematic comparison of four different treatments for casein depletion before extracellular vesicle isolation from human milk. | Extracell Vesicles Circ Nucl Acids | 2024 | 39698537 | PubTator, text mining | PubMed |
| Maternal BMI During Lactation Is Associated with Major Protein Compositions in Early Mature Milk. | Nutrients | 2024 | 39599598 | PubTator, text mining | PubMed |
| Integrated microbiome and metabolome analysis reveals the key role of taurohyocholate in the treatment of hyperuricemia with Lacticaseibacillus rhamnosus 2016SWU.05.0601. | Food Res Int | 2024 | 39593318 | PubTator, text mining | PubMed |
| Unveiling the role of phytochemicals in autism spectrum disorder by employing network pharmacology and molecular dynamics simulation. | Metab Brain Dis | 2024 | 39570464 | PubTator, text mining | PubMed |
| [Analysis of a family with hypouricemia due to type Ⅰ xanthinuria]. | Zhonghua Yi Xue Za Zhi | 2024 | 39533690 | PubTator, text mining | PubMed |
| Loss of Coral Trait Diversity and Impacts on Reef Fish Assemblages on Recovering Reefs. | Ecol Evol | 2024 | 39493612 | PubTator, text mining | PubMed |
| [Research advances on the metabolic pathways and functions mediated by plant xanthine dehydrogenase]. | Sheng Wu Gong Cheng Xue Bao | 2024 | 39467736 | PubTator, text mining | PubMed |
| The Role of Xanthine Oxidase in Pregnancy Complications: A Systematic Review. | Antioxidants (Basel) | 2024 | 39456486 | PubTator, text mining | PubMed |
| Insights into the biocompatibility of biodegradable metallic molybdenum for cardiovascular applications-a critical review. | Front Bioeng Biotechnol | 2024 | 39376544 | PubTator, text mining | PubMed |
| Efficient and low-complexity variable-to-variable length coding for DNA storage. | BMC Bioinformatics | 2024 | 39354338 | PubTator, text mining | PubMed |
| Allopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal Analysis. | Kidney Med | 2024 | 39347518 | PubTator, text mining | PubMed |
| Are cities under bright lights more innovative? Evidence from China. | Heliyon | 2024 | 39253158 | PubTator, text mining | PubMed |
| Inhibition of xanthine oxidase alleviated pancreatic necrosis via HIF-1α-regulated LDHA and NLRP3 signaling pathway in acute pancreatitis. | Acta Pharm Sin B | 2024 | 39220867 | PubTator, text mining | PubMed |
| Predicting novel targets with Bayesian machine learning by integrating multiple biological signatures. | Chem Sci | 2024 | 39170720 | PubTator, text mining | PubMed |
| Pharmacodynamic profiling in three patients with molybdenum cofactor deficiency type A reveals prolonged biological effects after withdrawal of cyclic pyranopterin monophosphate. | Mol Genet Metab | 2024 | 39168057 | PubTator, text mining | PubMed |
| Successful Kidney Transplantation in a Young Male with Type 2 Xanthinuria. | Indian J Nephrol | 2024 | 39156844 | PubTator, text mining | PubMed |
| Successful Management of Adenine Phosphoribosyl Transferase Enzyme Deficiency in Renal Transplantation: A Case Report. | Indian J Nephrol | 2024 | 39156833 | PubTator, text mining | PubMed |
| Loss of Cldn5 -and increase in Irf7-in the hippocampus and cerebral cortex of diabetic mice at the early symptomatic stage. | Nutr Diabetes | 2024 | 39147772 | PubTator, text mining | PubMed |
| Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol. | Rheumatology (Oxford) | 2024 | 39137147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7498/papers?page=13